Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mehdi Moradinazar

Biographic Data

ID7026082
NAMEMehdi Moradinazar
GIVEN NAMESMehdi
FAMILY NAMEMoradinazar
SIGNATUREMORADINAZAR M
AFFILIATIONSKermanshah University of Medical Sciences
ORCID0000-0001-7033-6755
VERIFIEDYes
TOTAL WORKS17
TOTAL CITATIONS0
WORKS AS AUTHOR17
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Association of individual and community-level socioeconomic status and education with medication use

    Open Access•Mohammadreza Akbari, Hossein Poustchi et al.•ARTICLE•BMC Public Health•2025

    Higher education was associated with lower medication use, whereas living in more educated communities was linked to higher usage. Although the association between individual SES and medication use was relatively weak, residing in middle-SES communities was associated with lower medication usage. These findings show the importance of addressing community-level factors in health research and policymaking

  • The mediating role of physical activity, morning wake-up time, and sleep-inducing medication use in the relationship between age and depression

    Open Access•Fahimeh Alsadat Hosseini, Samaneh Bagherian et al.•ARTICLE•BMC Public Health•2025

    We found evidence for a mediational effect of age on depression, as the biopsychosocial model of mental illness implies. The findings of this study can add to the existing body of knowledge on depression management and help clarify the mechanisms of the effect of age on depression

  • Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV

    Open Access•Shahin Soltani, Mehdi Moradinazar et al.•ARTICLE•BMC Public Health•2025

    The study indicates that AZD1222 booster doses are safe for individuals previously vaccinated with Sinopharm BBIBP-CorV, with rare adverse events and an acceptable safety profile. This supports the use of heterologous booster strategies, though ongoing monitoring and improved pharmacovigilance are essential to detect any potential long-term effects

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • A prospective cohort study protocol

    Open Access•Shahin Soltani, Behzad Karami Matin et al.•ARTICLE•BMC Public Health•2023

    With the planned study we will provide a valid epidemiological evidence to improve the understanding of the safety of the booster dose of the AstraZeneca and to better evaluate the effectiveness of public health interventions. This could help policy makers in managing the COVID-19 pandemic according to scientific evidence

  • The association between self-reported mobile phone usage with blood pressure and heart rate

    Open Access•Fatemeh Amiri, Mehdi Moradinazar et al.•ARTICLE•BMC Public Health•2022

    In this study, a significant decreasing trend was found between SBP, DBP, and HR and higher mobile phone usage in women. Based on regression analysis, SBP, DBP, and duration of mobile phone use were associated negatively in those who used their phones for at least 8 h

  • Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran

    Open Access•Omran Davarinejad, Tahereh Mohammadi Majd et al.•ARTICLE•International Journal of…•2021

    Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Pe…

  • Socioeconomic - related inequalities in overweight and obesity

    Open Access•Farid Najafi, Shahin Soltani et al.•ARTICLE•BMC Public Health•2020

    Overall, we found that overweight and obesity is concentrated among high SES people in the study population. . Accordingly, it seems that intersectional actions should be taken to control and prevent overweight and obesity among higher socioeconomic groups

  • Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran

    Open Access•Mehdi Moradinazar, Yahya Pasdar et al.•ARTICLE•BMC Public Health•2020

    As compared to non-smokers, current smokers and former smokers had abnormal HDL-C and triglyceride and abnormal total cholesterol and triglyceride, respectively. After quitting smoking, heavy smokers showed a more normal HDL-C and total cholesterol levels than the people who tended to smoke a lower number of cigarettes per day

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open Access•Valery L Feigin, Emma Nichols et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Socioeconomic gradient in physical activity

    Open Access•Ali Kazemi Karyani, Behzad Karmi Matin et al.•ARTICLE•BMC Public Health•2019

    The higher prevalence of PPA among Iranian adults, especially, women and older adults, warrant further public health attention. Since PPA is concentrated more among the high-SES population in Iran, strategies for the promotion of physical activity should focus more on economically well-off population

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open Access•Gregory A Roth, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open Access•Hmwe Hmwe Kyu, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017

    Open Access•L James, Spencer L James et al.•ARTICLE•The Lancet•2018

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal…

No prominent works on this page.

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open Access•Gregory A Roth, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open Access•Hmwe Hmwe Kyu, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017

    Open Access•L James, Spencer L James et al.•ARTICLE•The Lancet•2018

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal…

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open Access•Valery L Feigin, Emma Nichols et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Socioeconomic gradient in physical activity

    Open Access•Ali Kazemi Karyani, Behzad Karmi Matin et al.•ARTICLE•BMC Public Health•2019

    The higher prevalence of PPA among Iranian adults, especially, women and older adults, warrant further public health attention. Since PPA is concentrated more among the high-SES population in Iran, strategies for the promotion of physical activity should focus more on economically well-off population

  • Socioeconomic - related inequalities in overweight and obesity

    Open Access•Farid Najafi, Shahin Soltani et al.•ARTICLE•BMC Public Health•2020

    Overall, we found that overweight and obesity is concentrated among high SES people in the study population. . Accordingly, it seems that intersectional actions should be taken to control and prevent overweight and obesity among higher socioeconomic groups

  • Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran

    Open Access•Mehdi Moradinazar, Yahya Pasdar et al.•ARTICLE•BMC Public Health•2020

    As compared to non-smokers, current smokers and former smokers had abnormal HDL-C and triglyceride and abnormal total cholesterol and triglyceride, respectively. After quitting smoking, heavy smokers showed a more normal HDL-C and total cholesterol levels than the people who tended to smoke a lower number of cigarettes per day

  • Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran

    Open Access•Omran Davarinejad, Tahereh Mohammadi Majd et al.•ARTICLE•International Journal of…•2021

    Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Pe…

  • The association between self-reported mobile phone usage with blood pressure and heart rate

    Open Access•Fatemeh Amiri, Mehdi Moradinazar et al.•ARTICLE•BMC Public Health•2022

    In this study, a significant decreasing trend was found between SBP, DBP, and HR and higher mobile phone usage in women. Based on regression analysis, SBP, DBP, and duration of mobile phone use were associated negatively in those who used their phones for at least 8 h

  • A prospective cohort study protocol

    Open Access•Shahin Soltani, Behzad Karami Matin et al.•ARTICLE•BMC Public Health•2023

    With the planned study we will provide a valid epidemiological evidence to improve the understanding of the safety of the booster dose of the AstraZeneca and to better evaluate the effectiveness of public health interventions. This could help policy makers in managing the COVID-19 pandemic according to scientific evidence

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • Association of individual and community-level socioeconomic status and education with medication use

    Open Access•Mohammadreza Akbari, Hossein Poustchi et al.•ARTICLE•BMC Public Health•2025

    Higher education was associated with lower medication use, whereas living in more educated communities was linked to higher usage. Although the association between individual SES and medication use was relatively weak, residing in middle-SES communities was associated with lower medication usage. These findings show the importance of addressing community-level factors in health research and policymaking

  • The mediating role of physical activity, morning wake-up time, and sleep-inducing medication use in the relationship between age and depression

    Open Access•Fahimeh Alsadat Hosseini, Samaneh Bagherian et al.•ARTICLE•BMC Public Health•2025

    We found evidence for a mediational effect of age on depression, as the biopsychosocial model of mental illness implies. The findings of this study can add to the existing body of knowledge on depression management and help clarify the mechanisms of the effect of age on depression

  • Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV

    Open Access•Shahin Soltani, Mehdi Moradinazar et al.•ARTICLE•BMC Public Health•2025

    The study indicates that AZD1222 booster doses are safe for individuals previously vaccinated with Sinopharm BBIBP-CorV, with rare adverse events and an acceptable safety profile. This supports the use of heterologous booster strategies, though ongoing monitoring and improved pharmacovigilance are essential to detect any potential long-term effects

Medicine (16 works) · Environmental health (12 works) · Population (10 works) · Demography (9 works) · Internal Medicine (9 works) · Disease (7 works) · Epidemiology (7 works) · Biostatistics (6 works) · Cohort study (6 works) · Pathology (6 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae